GJB2-mediated hearing loss

Clinical trials for GJB2-mediated hearing loss explained in plain language.

Never miss a new study

Get alerted when new GJB2-mediated hearing loss trials appear

Sign up with your email to follow new studies for GJB2-mediated hearing loss, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

One-time gene therapy aims to restore hearing in kids with genetic deafness

Disease control Recruiting now

This early-stage trial tests a new gene therapy called SKY-GJB2 for children aged 9 months to 7 years with hearing loss caused by changes in the GJB2 gene. The therapy is given as a single injection into the inner ear using a special delivery device. The study will enroll 10 chil…

Matched conditions: GJB2-MEDIATED HEARING LOSS

Phase 1/2 • Sponsor: Skylark Bio Inc. • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC

GJB2-mediated hearing loss

Get alerted when new GJB2-mediated hearing loss trials appear

One-time gene therapy aims to restore hearing in kids with genetic deafness